openPR Logo
Press release

Biopharma PEG Announces FDA DMF Registration for mPEG-pAld (20K)

01-17-2025 01:29 PM CET | Health & Medicine

Press release from: Biopharma PEG Scientific Inc

Biopharma PEG Announces FDA DMF Registration for mPEG-pAld

Biopharma PEG, a leading manufacturer of high-quality polyethylene glycol (PEG) derivatives, today announced that its mPEG-pAld (20K) product has successfully achieved DMF (Drug Master File) II registration with the U.S. Food and Drug Administration (FDA) under DMF number 040600.
"We are thrilled to receive FDA DMF registration for our mPEG-pAld (20K) product," said Sonia Lee, Marketing Director at Biopharma PEG. "This achievement demonstrates our commitment to providing our customers with the highest quality materials for their drug development programs. We are confident that this registration will help to streamline and accelerate the development of new drugs."
mPEG-pAld (20K) is a monomethoxy poly(ethylene glycol) derivative with a p-aldehyde functional group. It is a versatile building block that can be used in a variety of applications, including:
• Drug conjugation
• Targeted drug delivery
• Bioconjugation
• Biomaterials science
Why Choose Biopharma PEG?
• Exceptional Purity and Consistency: Biopharma PEG's strict quality controls guarantee high purity and reliable batch-to-batch consistency, meeting global standards.
• Regulatory Expertise: FDA DMF certification ensures full regulatory support to streamline and accelerate drug development.
• GMP Standards: GMP-compliant production with support from R&D to kilogram-scale manufacturing, meeting diverse needs.
"We are committed to providing our customers with the best possible products and services," said Ms. Lee. "We look forward to working with our customers to bring new and innovative drugs to market."

Biopharma PEG Scientific Inc.
108 Water Street, Suite 4D, Watertown, MA 02472, USA
TEL: 1-857-928-2050 / 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com

Biopharma PEG is a leading manufacturer of high-quality PEG derivatives. The company offers a wide range of PEG products for use in the pharmaceutical, biotechnology, and other industries. Biopharma PEG is committed to providing its customers with exceptional quality products, regulatory expertise, and GMP-compliant manufacturing.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharma PEG Announces FDA DMF Registration for mPEG-pAld (20K) here

News-ID: 3819892 • Views:

More Releases from Biopharma PEG Scientific Inc

BIOPHARMA PEG Receives FDA DMF Listings for Two Key PEG Derivatives
BIOPHARMA PEG, a leading developer and supplier of high-purity polyethylene glycol (PEG) derivatives, today announced that two of its proprietary products-mPEG-pALD 20K and HZ-PEG-HZ (1K)-have successfully passed FDA review and are now listed in the U.S. Drug Master File (DMF) database. mPEG-pALD (20K) - DMF No. 040600 HZ-PEG-HZ (1K) - DMF No. 041864 These new listings mark a significant step in BIOPHARMA PEG's ongoing efforts to provide regulatory-ready, high-quality PEG solutions to the
Monodispersed PEG Linkers Enhance Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. Introducing polyethylene glycol (PEG) linkers between the antibody and drug payload can address this. PEG is hydrophilic, biologically inert, and FDA‐recognized as safe. As a flexible spacer, PEG "shields" the hydrophobic drug, greatly improving ADC solubility and stability. In fact,
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio at TIDES USA 2025
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio …
Biopharma PEG Scientific Inc., a leading provider of high-quality polyethylene glycol (PEG) derivatives, today announced its participation in TIDES USA 2025, taking place from May 19 - 22, 2025, at the Manchester Grand Hyatt San Diego. Attendees are invited to visit Biopharma PEG at Booth #913 to explore their extensive range of GMP-grade PEG products and discuss how these solutions can advance their research and development efforts. Biopharma PEG offers a
BIOPHARMA PEG Showcases DSPE-PEG-Mannose: A Cutting-Edge Polymer for Drug Delive …
Watertown, MA - March 24, 2025 - Biopharma PEG, a leading supplier of high-quality polyethylene glycol (PEG) derivatives, highlights its innovative product DSPE-PEG-Mannose, an advanced biomedical polymer with significant potential in drug delivery, tumor-targeted therapy, tissue recognition, and adhesion. Structural Advantages of DSPE-PEG-Mannose DSPE-PEG-Mannose is composed of three key components that enable its diverse applications: DSPE (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine): A phospholipid with amphiphilic properties, forming stable micelles in aqueous solutions. PEG (Polyethylene Glycol): A biocompatible polymer

All 5 Releases


More Releases for DMF

BIOPHARMA PEG Receives FDA DMF Listings for Two Key PEG Derivatives
BIOPHARMA PEG, a leading developer and supplier of high-purity polyethylene glycol (PEG) derivatives, today announced that two of its proprietary products-mPEG-pALD 20K and HZ-PEG-HZ (1K)-have successfully passed FDA review and are now listed in the U.S. Drug Master File (DMF) database. mPEG-pALD (20K) - DMF No. 040600 HZ-PEG-HZ (1K) - DMF No. 041864 These new listings mark a significant step in BIOPHARMA PEG's ongoing efforts to provide regulatory-ready, high-quality PEG solutions to the
Huateng Pharma's mPEG-pALD Receives FDA DMF Filing Approval
Changsha, China - Hunan Huateng Pharmaceutical Co., Ltd. (Huateng Pharma), a global leader in the development and production of high-quality PEG derivatives, is pleased to announce that its mPEG-pALD (20K) has successfully completed its Drug Master File (DMF) filing with the U.S. Food and Drug Administration (FDA), under DMF No. 040600. This achievement highlights Huateng Pharma's dedication to meeting the highest regulatory standards and further strengthens its commitment to supporting
Dimethylformamide (DMF) Market Share, Key Market Players, Trends & Forecast, 202 …
New York, United States, - The growth of the Dimethylformamide (DMF) Market is driven by several key factors, including its extensive use as a solvent in various industries and the rising demand for high-performance chemicals in manufacturing processes. DMF is a versatile organic solvent with excellent solvency properties, making it essential in the production of pharmaceuticals, agrochemicals, and synthetic fibers. The pharmaceutical industry, in particular, relies heavily on DMF for
Global Dimethylformamide (DMF) Market Statistics, Segment, Trends and Forecast t …
Dimethylfomamide (DMF) Market size stood at USD 768.44 Million in 2022 and is projected to reach USD 1,139.09 Million, by 2032. Growing at a CAGR of 13.44% during the forecast period i.e. 2023-2032. The rising demand for dimethylformamide (DMF) from a variety of end-use sectors, including the chemical, pharmaceutical, electronics, and agrochemical industries, is responsible for the rise of the DMF Market globally. The global dimethylformamide (DMF) market is expanding as
DMF (Dimethylformamide) Production Cost Analysis Report, Raw Materials Requireme …
The latest report titled "DMF (Dimethylformamide) Production Cost Report" by Procurement Resource, a global procurement research and consulting firm, provides an in-depth cost analysis of the production process of the DMF (Dimethylformamide). Product Name - DMF (Dimethylformamide) Process Included - Aluminium Can Production from Two-Piece or Three-Piece Drawing Currency US$ (Data can also be provided in local currency) Customization Scope - The report can be customized as per the requirements of the customer Post-Sale Analyst Support - 360-degree analyst
DMF Price Chart, Historical and Forecast Analysis Provided by Procurement Resour …
Product Name - DMF HS Code - 29211110 Molecular Weight - 73.09g/mol Chemical Formula - C3H7NO Synonyms - Dimethylformamide, 68-12-2, Dimethyl formamide, N,N-Dimethylmethanamide Currency - US$ (Data can also be provided in local currency) Supplier Database Availability - Yes Customization Scope - Our services can be customized as per the requirements of the customer Post-Sale Analyst Support - 360-degree analyst support after service delivery Region/Countries for which Data is available Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam,